Sedana Medical AB (publ) (SEDANA.ST)
SEK 16.0
(0.38%)
SEK 16.0
(0.38%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.3 Million SEK | -50.75% |
| 2022 | 8.74 Million SEK | -1.48% |
| 2021 | 8.87 Million SEK | 7.03% |
| 2020 | 8.29 Million SEK | 226.8% |
| 2019 | 2.53 Million SEK | 0.0% |
| 2018 | - SEK | -100.0% |
| 2017 | 3600.00 SEK | -99.93% |
| 2016 | 4.91 Million SEK | -13.87% |
| 2015 | 5.71 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 7.9 Million SEK | 84.67% |
| 2024 Q1 | 4.27 Million SEK | -0.65% |
| 2024 Q3 | 3.73 Million SEK | -8.33% |
| 2023 Q3 | 5.33 Million SEK | -21.14% |
| 2023 Q4 | 4.3 Million SEK | -19.35% |
| 2023 FY | 4.3 Million SEK | -50.75% |
| 2023 Q1 | 8.06 Million SEK | -7.71% |
| 2023 Q2 | 6.77 Million SEK | -16.1% |
| 2022 FY | 8.74 Million SEK | -1.48% |
| 2022 Q2 | 9.39 Million SEK | -4.8% |
| 2022 Q3 | 8.74 Million SEK | -6.9% |
| 2022 Q4 | 8.74 Million SEK | 0.0% |
| 2022 Q1 | 9.86 Million SEK | 11.16% |
| 2021 Q1 | 8.57 Million SEK | 3.47% |
| 2021 Q2 | 9.19 Million SEK | 7.16% |
| 2021 FY | 8.87 Million SEK | 7.03% |
| 2021 Q4 | 8.87 Million SEK | -1.71% |
| 2021 Q3 | 9.02 Million SEK | -1.79% |
| 2020 Q1 | - SEK | -100.0% |
| 2020 FY | 8.29 Million SEK | 226.8% |
| 2020 Q4 | 8.29 Million SEK | 0.0% |
| 2020 Q3 | - SEK | 0.0% |
| 2020 Q2 | - SEK | 0.0% |
| 2019 Q4 | 2.53 Million SEK | 0.0% |
| 2019 FY | 2.53 Million SEK | 0.0% |
| 2019 Q1 | - SEK | -100.0% |
| 2019 Q2 | - SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2018 Q4 | 2.27 Million SEK | 0.0% |
| 2018 FY | - SEK | -100.0% |
| 2018 Q1 | 57.45 Thousand SEK | 1496.0% |
| 2018 Q2 | - SEK | -100.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2017 Q3 | 539.85 Thousand SEK | -91.82% |
| 2017 Q2 | 6.59 Million SEK | -39.07% |
| 2017 FY | 3600.00 SEK | -99.93% |
| 2017 Q4 | 3600.00 SEK | -99.33% |
| 2017 Q1 | 10.83 Million SEK | 120.23% |
| 2016 Q4 | 4.91 Million SEK | 0.0% |
| 2016 FY | 4.91 Million SEK | -13.87% |
| 2015 FY | 5.71 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.733% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.733% |
| Arcoma AB | 3.87 Million SEK | -11.18% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | 98.153% |
| BICO Group AB (publ) | 1.85 Billion SEK | 99.768% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | 97.408% |
| CellaVision AB (publ) | 64.7 Million SEK | 93.345% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -848.458% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -139.222% |
| Duearity AB (publ) | 10.58 Million SEK | 59.308% |
| Dignitana AB (publ) | 19.1 Million SEK | 77.46% |
| Episurf Medical AB (publ) | 5.2 Million SEK | 17.192% |
| Getinge AB (publ) | 8.07 Billion SEK | 99.947% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | 47.804% |
| Iconovo AB (publ) | 7.72 Million SEK | 44.258% |
| Integrum AB (publ) | 6.42 Million SEK | 32.972% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -1990.048% |
| Mentice AB (publ) | 9.55 Million SEK | 54.944% |
| OssDsign AB (publ) | 3.15 Million SEK | -36.698% |
| Paxman AB (publ) | 13.57 Million SEK | 68.268% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | 79.229% |
| SciBase Holding AB (publ) | 6.79 Million SEK | 36.649% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | 86.454% |
| Senzime AB (publ) | 11.46 Million SEK | 62.452% |
| SpectraCure AB (publ) | 6.71 Million SEK | 35.894% |
| Stille AB | 62.94 Million SEK | 93.159% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 99.794% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | 86.303% |